RA Capital Management

Latest statistics and disclosures from Ra Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Ra Capital Management

Companies in the Ra Capital Management portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A S Sponsored Adr (ASND) 13.7 $978M 5.9M 166.78
Tg Therapeutics (TGTX) 6.3 $452M 8.7M 52.02
Novavax Com New (NVAX) 5.9 $423M +216% 3.8M 111.51
Nkarta (NKTX) 4.8 $345M 5.6M 61.47
Forma Therapeutics Hldgs SHS (FMTX) 4.4 $315M 9.0M 34.90
Arvinas Ord (ARVN) 4.4 $312M 3.7M 84.93
Chemocentryx (CCXI) 4.1 $296M 4.8M 61.92
Atea Pharmaceuticals (AVIR) 3.1 $224M NEW 5.4M 41.78
Iteos Therapeutics (ITOS) 2.1 $149M 4.4M 33.82
Kinnate Biopharma (KNTE) 2.0 $143M NEW 3.6M 39.78
Axsome Therapeutics (AXSM) 1.9 $135M -18% 1.7M 81.47
Keros Therapeutics (KROS) 1.8 $132M 1.9M 70.54
Phathom Pharmaceuticals (PHAT) 1.8 $127M 3.8M 33.22
Rhythm Pharmaceuticals (RYTM) 1.7 $124M -18% 4.2M 29.73

Setup an alert

RA Capital Management will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Travere Therapeutics (TVTX) 1.7 $124M NEW 4.6M 27.26
ImmunoGen (IMGN) 1.7 $119M +161% 18M 6.45
Rocket Pharmaceuticals (RCKT) 1.6 $117M NEW 2.1M 54.84
89bio (ETNB) 1.6 $115M 4.7M 24.37
Zogenix Com New (ZGNX) 1.5 $107M -2% 5.3M 19.99
Pmv Pharmaceuticals (PMVP) 1.5 $105M 1.7M 61.51
Olema Pharmaceuticals (OLMA) 1.4 $103M NEW 2.2M 48.08
Adverum Biotechnologies (ADVM) 1.4 $103M 9.5M 10.84
Macrogenics (MGNX) 1.4 $100M 4.4M 22.86
Vaxcyte (PCVX) 1.4 $99M -29% 3.7M 26.57
Igm Biosciences (IGMS) 1.2 $87M 983k 88.29
Black Diamond Therapeutics (BDTX) 1.2 $83M 2.6M 32.05
Silverback Therapeutics (SBTX) 1.1 $81M NEW 1.7M 46.34
Trillium Therapeutics Com New (TRIL) 1.1 $78M -14% 5.3M 14.71
Solid Biosciences (SLDB) 1.1 $76M +118% 10M 7.58
Kala Pharmaceuticals (KALA) 1.0 $74M 11M 6.78
Five Prime Therapeutics (FPRX) 1.0 $73M NEW 4.3M 17.01
Inhibrx (INBX) 1.0 $70M 2.1M 32.97
Legend Biotech Corp Sponsored Ads (LEGN) 0.9 $68M 2.4M 28.16
Curis Com New (CRIS) 0.9 $63M NEW 7.7M 8.19
Wave Life Sciences SHS (WVE) 0.9 $61M 7.8M 7.87
Cardiff Oncology (CRDF) 0.8 $59M 3.3M 17.99
Dyne Therapeutics (DYN) 0.8 $59M 2.8M 21.00
Constellation Pharmceticls I (CNST) 0.7 $53M NEW 1.9M 28.80
Pacific Biosciences of California (PACB) 0.7 $52M NEW 2.0M 25.94
Geron Corporation (GERN) 0.7 $48M 30M 1.59
Sutro Biopharma (STRO) 0.6 $46M 2.1M 21.71
C4 Therapeutics Com Stk (CCCC) 0.6 $46M NEW 1.4M 33.13
Akouos (AKUS) 0.6 $45M 2.3M 19.83
Relay Therapeutics (RLAY) 0.6 $42M 1.0M 41.56
Inozyme Pharma (INZY) 0.6 $41M 2.0M 20.64
Orchard Therapeutics Ads (ORTX) 0.6 $41M 12M 3.34
Ardelyx (ARDX) 0.6 $40M 6.2M 6.47
Cerevel Therapeutics Hldng I (CERE) 0.5 $37M NEW 2.2M 16.58
Arcutis Biotherapeutics (ARQT) 0.5 $33M 1.2M 28.13
Larimar Therapeutics (LRMR) 0.5 $32M 1.5M 21.41
Verona Pharma Sponsored Ads (VRNA) 0.4 $32M 5.1M 6.24
Pandion Therapeutics (PAND) 0.4 $26M 1.8M 14.85
Alector (ALEC) 0.3 $25M -55% 1.6M 15.13
Concert Pharmaceuticals I equity (CNCE) 0.3 $23M 1.8M 12.64
Syndax Pharmaceuticals (SNDX) 0.3 $23M 1.0M 22.24
Satsuma Pharmaceuticals Ord (STSA) 0.3 $22M 4.7M 4.61
Oric Pharmaceuticals (ORIC) 0.3 $20M NEW 584k 33.85
Scpharmaceuticals (SCPH) 0.3 $19M 3.5M 5.29
Marinus Pharmaceuticals Com New (MRNS) 0.2 $16M NEW 1.3M 12.20
Vaxart Com New (VXRT) 0.2 $16M -74% 2.7M 5.71
Milestone Pharmaceuticals (MIST) 0.2 $16M -3% 2.3M 6.70
Ocular Therapeutix (OCUL) 0.2 $16M -72% 750k 20.70
Bctg Acquisition Corp (BCTG) 0.2 $14M 1.3M 11.44
Repare Therapeutics Ord (RPTX) 0.2 $14M 409k 34.30
Bcls Acquisition Corp Com Cl A (BLSA) 0.2 $14M NEW 1.3M 11.14
Adaptimmune Therapeutics Sponds Adr (ADAP) 0.2 $14M -77% 2.5M 5.39
Cogent Biosciences (COGT) 0.2 $12M NEW 1.0M 11.23
Arya Sciences Acquisition Com Cl A (ARYA) 0.2 $11M 1.0M 10.85
Frazier Lifesciences Acquisition Unit 12/09/2025 (FLACU) 0.1 $10M NEW 1.0M 10.38
Therapeuticsmd (TXMD) 0.1 $9.5M NEW 7.8M 1.21
Lyra Therapeutics (LYRA) 0.1 $9.3M 816k 11.40
Passage Bio (PASG) 0.1 $8.3M 323k 25.57
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.1 $8.0M 625k 12.81
Crinetics Pharmaceuticals In (CRNX) 0.1 $8.0M -75% 564k 14.11
Helix Acquisition Corp Com Cl A (HLXA) 0.1 $8.0M NEW 700k 11.37
5 01 Acquisition Corp Com Cl A (FVAM) 0.1 $7.6M NEW 750k 10.17
Miragen Therapeutics Com New 0.1 $7.4M NEW 452k 16.45
Imara (IMRA) 0.1 $5.5M 249k 22.05
Profound Medical Corp Com New (PROF) 0.1 $4.0M NEW 192k 20.56
X4 Pharmaceuticals (XFOR) 0.0 $3.5M -4% 537k 6.43
Cerevel Therapeutics Hldng *w Exp 06/09/2027 (CEREW) 0.0 $1.3M NEW 233k 5.65
Ovid Therapeutics (OVID) 0.0 $658k 285k 2.31

Past Filings by Ra Capital Management

SEC 13F filings are viewable for Ra Capital Management going back to 2010

View all past filings